These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Black box warnings in prescription drug labeling: results of a survey of 206 drugs. Beach JE; Faich GA; Bormel FG; Sasinowski FJ Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718 [No Abstract] [Full Text] [Related]
4. MedGuide: at last a long-sought opportunity for patient education about prescription drugs. Marwick C JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654 [No Abstract] [Full Text] [Related]
5. Rules set for dissemination of off-label-use information. Miller JL Am J Health Syst Pharm; 1999 Feb; 56(3):204. PubMed ID: 10030500 [No Abstract] [Full Text] [Related]
6. A defense of the learned intermediary doctrine. Goetz RB; Growdon KR Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470 [No Abstract] [Full Text] [Related]
7. Official written patient drug-use information. Heller WM Drug Inf J; 1978; 12(1):59-62. PubMed ID: 10308109 [No Abstract] [Full Text] [Related]
8. The new USP-NF: drug standards and patient information. Heller WM Hosp Formul; 1980 Jan; 15(1):21-4. PubMed ID: 10244954 [No Abstract] [Full Text] [Related]
9. FDA delays proposal on patient drug information. Am J Health Syst Pharm; 1995 Feb; 52(4):355-6. PubMed ID: 7757853 [No Abstract] [Full Text] [Related]
10. Editorial: Standardization of drug names. Lewis JR JAMA; 1974 Jul; 229(5):559-60. PubMed ID: 4406902 [No Abstract] [Full Text] [Related]
11. [The influence of the drug legislation on drug information for the physician and patient]. Schwabe U Internist (Berl); 1980 Jun; 21(6):311-7. PubMed ID: 7005167 [No Abstract] [Full Text] [Related]
12. Drug information risks under the Freedom of Information Act. Cuddihy RV Drug Inf J; 1978; 12(1):40-4. PubMed ID: 10308104 [No Abstract] [Full Text] [Related]
13. Drug information to contain NAC study results. Pa Med; 1972 Jul; 75(7):20. PubMed ID: 5032310 [No Abstract] [Full Text] [Related]
14. Stoning a dead bird: advertising limits on approved new drugs. Strobos J Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018 [No Abstract] [Full Text] [Related]
15. Doctor, what should pharmacists tell your patients about the drugs you prescribe? Valentino JG Hosp Formul; 1975 Jun; 10(6):255-7. PubMed ID: 10237840 [No Abstract] [Full Text] [Related]
16. What drug labels don't tell you. Consum Rep; 2011 Aug; 76(8):10. PubMed ID: 21770080 [No Abstract] [Full Text] [Related]
17. FDA off-track on off-label drug promotion. Lancet; 2007 Dec; 370(9604):1976. PubMed ID: 18083382 [No Abstract] [Full Text] [Related]
18. Government and drug information--the FDA. Groth PE Drug Inf J; 1978; 12(1):33-6. PubMed ID: 10308103 [No Abstract] [Full Text] [Related]
19. The medicolegal significance of the package insert. Hirsh HL Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155 [No Abstract] [Full Text] [Related]
20. Processing and evaluation of adverse drug experience reports at the Food and Drug Administration Center for Veterinary Medicine. Keller WC; Bataller N; Oeller DS J Am Vet Med Assoc; 1998 Jul; 213(2):208-11. PubMed ID: 9676589 [No Abstract] [Full Text] [Related] [Next] [New Search]